Now You Can Help Make the Alethus 2.0 Device a Reality

  • Pilot Clinical Trial to be Conducted Following a Protocol Under the IDE (Investigational Device Exemption, FDA) at a Leading Institution
  • Confirmation Product Works Across Full Range
  • FDA Approval Process
  • Manufacturing and Marketing of Devices

We are currently raising funds for the development of our 2.0 device to demonstrate high accuracy across the physiological range of insulin secretion and concentration. This 2.0 device will be used in a pilot clinic trial and pave the development path towards our pivotal trials.
If you are an Accredited Investor as defined by the Securities and Exchange Commission (SEC) under Regulation D (refers to investors who are financially sophisticated and have a reduced need for the protection provided by certain government filings), would be interested in investing a minimum of $10,000, and would like to learn more about investing in Alethus, Seed B Preferred Financing, please click on one of the links below:
© 2014 Alethus - All rights reserved.